If this article matches what you are dealing with, our team can help you choose the right service
That could be the same kind of story because there's also additional biology on that one
Viking Therapeutics: Vikings investigational drug VK2735, a dual GLP-1/GIP receptor agonist, demonstrated promising weight loss results in Phase 1/2 studies, positioning it as a potential competitor to semaglutide
It is important to note that whilst Ozempic has gained attention for weight loss, its primary licensed indication in the UK remains the treatment of type 2 diabetes
Weight loss on semaglutide can be supported by maintaining a balanced, protein-rich diet, staying physically active, getting adequate sleep, and following your prescribed dosing schedule